Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab

Sylvie Fabre; Christelle Gibert; Catherine Lechiche; Christian Jorgensen; Jacques Sany

Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab

J Rheumatol. 2005 Dec;32(12):2432-3.

Authors

Sylvie Fabre¹, Christelle Gibert, Catherine Lechiche, Christian Jorgensen, Jacques Sany

Affiliation

¹ Department of Immuno-Rheumatology, Centre Hospitalier Universitaire Lapeyronie, Montpellier, France.

PMID: 16331777

Abstract

Anti-tumor necrosis factor-a (anti-TNF-a) therapy strategies result in significant clinical benefits in patients with rheumatoid arthritis, but with an increased rate of serious infectious diseases. We describe a patient receiving infliximab who developed a primary cutaneous Nocardia otitidiscaviarum infection after a skin injury.

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / therapeutic use
Antirheumatic Agents / adverse effects*
Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid / complications
Arthritis, Rheumatoid / drug therapy*
Diabetes Mellitus, Type 1 / complications
Humans
Infliximab
Male
Nocardia Infections / chemically induced*
Nocardia Infections / pathology
Skin / injuries
Skin Diseases, Bacterial / chemically induced*
Skin Diseases, Bacterial / pathology
Tumor Necrosis Factor-alpha / antagonists & inhibitors
Wounds and Injuries / microbiology

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Tumor Necrosis Factor-alpha
Infliximab